Copper‐associated chronic hepatitis in Cavalier King Charles spaniels
Veterinary Record · 03.02.2024 · 194 (3)
DOI: 10.1002/vetr.3561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 05.11.2023. Verfasst von Ran Nivy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ben-Shemen Specialist Referral Centre, Ben-Shemen, Israel. Hauptthemen laut MEDLINE: Hypertension, Portal, Dog Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Copper‐associated chronic hepatitis (CuCH) is poorly characterised in Cavalier King Charles spaniels (CKCS).
Methods
Hepatic copper accumulation was qualitatively and quantitatively assessed, and blood samples were used for genetic testing to screen for known CuCH‐associated genetic variants.
Results
The study included 13 CKCS with CuCH and eight unaffected controls. Increased transaminase activities, elevated biliary enzyme concentrations and portal hypertension were documented in 100%, 73% and 38% of dogs with CuCH, respectively. Five dogs had three or more abnormalities in measures of liver function. All 11 dogs with CuCh that underwent genetic testing were homozygous negative for the COMMD1 deletion and ATP7A variant but homozygous positive ( n = 7) or heterozygous ( n = 4) for the ATP7B variant. Liver histology often demonstrated marked architectural distortion by severe, bridging fibrosis and regenerative nodules with lymphoplasmacytic inflammation. Centrilobular copper accumulation characterised early cases with minimal fibrosis. When fibrosis was significant, copper was often differentially concentrated within regenerative nodules. Chelation therapy resolved laboratory derangements and portal hypertension in five of seven dogs. Of the 7 non‐surviving dogs with CuCH, 6 had not received chelation therapy.
Limitations
Limitations include a small cohort size and the lack of pedigree analyses to corroborate heritability.
Conclusions
CuCH should be considered in CKCS with suspected liver disease. Long‐term prognosis seems favourable in dogs receiving chelation therapy, notwithstanding the presence of previously reported negative prognostic markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ben-Shemen Specialist Referral Centre, Ben-Shemen, Israel.
- Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.
- Animal DNA diagnostics, Cambridge, UK.
- Department of Veterinary Medicine, Queen's Veterinary School Hospital, University of Cambridge, Cambridge, UK.
- Willows Veterinary Centre & Referral Service, Solihull, UK.
- Kimron Veterinary Institute, Bet Dagan, Israel.
ORCID-Profile: Ran Nivy, Sharon Kuzi, Penny Watson
Zitieren
APA
Nivy, R., Kuzi, S., Swinburne, J., Constantino-Casas, F., Gajanayake, I., Bruchim, Y., Berkowitz, A., & Watson, P. (2024). Copper‐associated chronic hepatitis in Cavalier King Charles spaniels. Veterinary Record, 194(3). https://doi.org/10.1002/vetr.3561
Vancouver
Nivy R, Kuzi S, Swinburne J, Constantino-Casas F, Gajanayake I, Bruchim Y, et al. Copper‐associated chronic hepatitis in Cavalier King Charles spaniels. Veterinary Record. 2024;194(3). doi:10.1002/vetr.3561
BibTeX
@article{Nivy2024,
author = {Nivy, Ran and Kuzi, Sharon and Swinburne, June and Constantino-Casas, Fernando and Gajanayake, Isuru and Bruchim, Yaron and Berkowitz, Asaf and Watson, Penny},
title = {Copper‐associated chronic hepatitis in Cavalier King Charles spaniels},
journal = {Veterinary Record},
year = {2024},
volume = {194},
number = {3},
doi = {10.1002/vetr.3561}
}
EUVIMED